China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,556 | 82,236 | 104,338 | 69,175 | 34,339 |
| Depreciation Amortization | 4,730 | 12,909 | 10,104 | 6,727 | 3,480 |
| Income taxes - deferred | -846 | -3,253 | -1,770 | -166 | 267 |
| Accounts receivable | -15,506 | -39,919 | -37,784 | -26,068 | -17,571 |
| Accounts payable and accrued liabilities | -1,943 | 977 | -89 | 33 | 379 |
| Other Working Capital | -24,806 | -23,355 | -61,989 | -53,300 | -32,266 |
| Other Operating Activity | 24,149 | 72,589 | 59,750 | 40,495 | 24,405 |
| Operating Cash Flow | $23,335 | $102,184 | $72,559 | $36,897 | $13,033 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -137,083 | N/A | N/A | N/A | N/A |
| PPE Investments | -11,038 | -37,440 | -27,710 | -15,951 | -8,933 |
| Net Acquisitions | 97,702 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -84,829 | -22,669 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -256 | -787 | -734 | -667 | -151 |
| Other Investing Activity | -256 | -787 | -734 | -667 | -151 |
| Investing Cash Flow | $-135,503 | $-60,895 | $-28,443 | $-16,618 | $-9,085 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 23,009 | 23,009 | 23,009 | 8,715 |
| Common Stock Issued | 339 | 868 | 837 | 506 | 99 |
| Dividend Paid | N/A | -18,789 | -18,789 | N/A | N/A |
| Other Financing Activity | 0 | -23,412 | -23,412 | -8,715 | 0 |
| Financing Cash Flow | $339 | $-18,324 | $-18,355 | $14,801 | $8,814 |
| Exchange Rate Effect | 10,697 | 12,607 | 6,918 | 4,399 | 830 |
| Beginning Cash Position | 219,337 | 183,766 | 183,766 | 183,766 | 183,766 |
| End Cash Position | 118,205 | 219,337 | 216,445 | 223,244 | 197,357 |
| Net Cash Flow | $-101,132 | $35,571 | $32,680 | $39,478 | $13,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,335 | 102,184 | 72,559 | 36,897 | 13,033 |
| Capital Expenditure | -11,048 | -37,504 | -27,756 | -15,976 | -8,937 |
| Free Cash Flow | 12,286 | 64,680 | 44,804 | 20,921 | 4,096 |